The same study highlighted PPARγ as an important mediator of gut–brain communication and suggested it could serve as a future therapeutic target for probiotic or synbiotic approaches in managing complex chronic diseases such as Alzheimer’s disease [68]. Here, PPARG is linked to Alzheimer disease.